These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7089781)

  • 1. Treatment of homozygous familial hypercholesterolaemia with probucol.
    Baker SG; Joffe BI; Mendelsohn D; Seftel HC
    S Afr Med J; 1982 Jul; 62(1):7-11. PubMed ID: 7089781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment with probucol of children with familial hypercholesterolaemia.
    Sanjurjo P; Martul P; Sasieta M; Lafuente P; Ariza F; Cabeza I
    Acta Paediatr Scand; 1988 Jan; 77(1):132-5. PubMed ID: 3285634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of probucol on homozygous cases of familial hypercholesterolemia.
    Yamamoto A; Matsuzawa Y; Kishino B; Hayashi R; Hirobe K; Kikkawa T
    Atherosclerosis; 1983 Aug; 48(2):157-66. PubMed ID: 6615580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of probucol on plasma lipoproteins in polygenic and familial hypercholesterolaemia.
    Cortese C; Marenah CB; Miller NE; Lewis B
    Atherosclerosis; 1982 Sep; 44(3):319-25. PubMed ID: 7150396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Serum cholesterol and triglyceride levels in patients with type II hyperlipoproteinemia treated with probucol].
    Markiewicz M; Rymar B; Horubała-Bielak G; Koziara Z
    Wiad Lek; 1984 Oct; 37(19):1489-93. PubMed ID: 6528586
    [No Abstract]   [Full Text] [Related]  

  • 6. A comparison of cholestyramine and probucol in the treatment of familial hypercholesterolaemia.
    Jones DB; Simpson HC; Slaughter P; Lousley S; Carter RD; Cobbe SM; Mann JI
    Atherosclerosis; 1984 Oct; 53(1):1-7. PubMed ID: 6388586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New combined therapy of niceritrol and probucol on heterozygous familial hypercholesterolemia.
    Yamamoto K; Fukushima N; Ozaki I; Setoguchi Y; Yanagita T; Sakai T
    Artery; 1991; 18(3):133-49. PubMed ID: 2069518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probucol. A reappraisal of its pharmacological properties and therapeutic use in hypercholesterolaemia.
    Buckley MM; Goa KL; Price AH; Brogden RN
    Drugs; 1989 Jun; 37(6):761-800. PubMed ID: 2667936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diet and probucol in lowering cholesterol concentrations. Additive effects on plasma cholesterol concentrations in patients with familial type ii hyperlipoproteinemia.
    LeLorier J; DuBreuil-Quidoz S; Lussier-Cacan S; Huang YS; Davignon J
    Arch Intern Med; 1977 Oct; 137(10):1429-34. PubMed ID: 335998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of familial and non-familial hypercholesterolaemia: a review of HMG-CoA reductase inhibitors and probucol.
    Tikkanen MJ; Helve E; Nikkilä EA
    Eur Heart J; 1987 Aug; 8 Suppl E():97-101. PubMed ID: 3315684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of combined probucol-colestipol treatment for familial hypercholesterolemia and coronary artery disease.
    Kuo PT; Wilson AC; Kostis JB; Moreyra AE
    Am J Cardiol; 1986 Jun; 57(16):43H-48H. PubMed ID: 3524177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of medium-term probucol treatment on plasma lipids and lipoproteins. 16 cases of type IIa and IIb hyperlipoproteinaemia (author's transl)].
    Rouffy J; Chanu B; Bakir R; Goy-Loepper J; Saya C
    Nouv Presse Med; 1980 Oct; 9(40):3014-7. PubMed ID: 7443443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of severe and mild hypercholesterolaemia with probucol and neomycin.
    Miettinen TA; Toivonen I
    Postgrad Med J; 1975; 51(8):suppl 71-5. PubMed ID: 215985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-blind, placebo-controlled, cross-over trial of probucol in heterozygous familial hypercholesterolaemia.
    Durrington PN; Miller JP
    Atherosclerosis; 1985 May; 55(2):187-94. PubMed ID: 3890872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of probucol and cholestyramine combination therapy in severe familial hypercholesterolaemia.
    Jackson JM; Lee HA
    Atherosclerosis; 1984; 51(2-3):189-97. PubMed ID: 6743378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical research on the hypolipidemic action of a probucol preparation].
    Naumova R; Kerekovska M; Goranov I; Balabanski L
    Vutr Boles; 1986; 25(2):73-7. PubMed ID: 3716382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Probucol : comparison of its effect with that of a placebo in hyperlipoproteinemia type II].
    Beaumont V
    Nouv Presse Med; 1980 Oct; 9(40):3011-3. PubMed ID: 7443442
    [No Abstract]   [Full Text] [Related]  

  • 18. The long-term effects of probucol on serum lipid levels.
    McCaughan D
    Arch Intern Med; 1981 Oct; 141(11):1428-32. PubMed ID: 7025778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet function in familial hypercholesterolaemia in South Africa and the effects of probucol.
    Bradlow BA; Chetty N; Birnbaum M; Baker SG; Seftel HC
    Thromb Res; 1982 Apr; 26(2):91-9. PubMed ID: 6214040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of probucol on serum cholesterol concentration in primary hyperlipoproteinemia].
    Kawecka-Jaszcz K; Kocemba J; Wasowicz B; Król W
    Kardiol Pol; 1982; 25(5-6):377-82. PubMed ID: 6759746
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.